FOLLICULAR NHL IN TREATMENT WITH R-CHOP AND RITUXIMAB FOR MAINTENANCE, OUR EXPERIENCE

被引：0
|
作者：
Nadal Paula, Ortega [1 ]
Jose David, Gonzalez San Miguel [1 ]
Khoury Cristina, Romero [1 ]
Mesa Susej, Guedes [1 ]
Maria del Carmen, Losada Castillo [1 ]
Martin Manuel, Tapia [1 ]
Fuertes Fernando, Fernandez [1 ]
Quintana Cristina, Lemes [1 ]
Ruiz Ylenia, Morales [1 ]
Jose Miguel, Bosch Benitez [1 ]
Gomez Mar, Caballero [1 ]
机构：
[1] Complejo Hosp Univ Insular Materno Infantil, Las Palmas Gran Canaria, Spain
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-239
引用
收藏
页码：297 / 298
页数：2
相关论文
共 50 条
  • [21] Analysis of efficacy and safety of aprepitant in R-CHOP or R-TCOP chemotherapy for NHL
    Seki, Yoshinobu
    Mitsuko, Ooba
    Miyakoshi, Syukuko
    ANNALS OF ONCOLOGY, 2015, 26 : 93 - 93
  • [22] R-CHOP strikes again with survival benefit in follicular lymphoma
    Wilson, WH
    BLOOD, 2005, 106 (12) : 3678 - 3679
  • [23] Quantification of MRD in rituximab plus CHOP (R-CHOP) therapy in follicular lymphoma (FL): Results of a randomized trial comparing the concurrent and sequential administrations
    Kinoshita, T
    Hanyu, K
    Yuge, M
    Nagai, H
    Naoe, T
    Morishima, Y
    Itoh, K
    Hotta, T
    Enami, J
    Tobinai, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 608S - 608S
  • [24] What is the role of maintenance rituximab in follicular NHL? The Maloney article reviewed
    Hainsworth, John D.
    ONCOLOGY-NEW YORK, 2008, 22 (01): : 26 - +
  • [25] First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis
    Pouyiourou, M.
    Meyer, A.
    Stroux, A.
    Viardot, A.
    La Rosee, P.
    Maschmeyer, G.
    Kaempfe, D.
    Kahl, C.
    Vucinic, V.
    Monecke, A.
    Hirt, C.
    Weber, T.
    Meissner, J.
    Witzens-Harig, M.
    Boettcher, S.
    Schmalenberg, H.
    Marks, R.
    Prange-Krex, G.
    Kroschinsky, F.
    Hauf, E.
    Keller, U.
    Koch, K.
    Klapper, W.
    Herold, M.
    Scholz, Christian W.
    ANNALS OF HEMATOLOGY, 2020, 99 (12) : 2821 - 2829
  • [26] First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis
    M. Pouyiourou
    A. Meyer
    A. Stroux
    A. Viardot
    P. La Rosée
    G. Maschmeyer
    D. Kämpfe
    C. Kahl
    V. Vucinic
    A. Monecke
    C. Hirt
    T. Weber
    J. Meissner
    M. Witzens-Harig
    S. Böttcher
    H. Schmalenberg
    R. Marks
    G. Prange-Krex
    F. Kroschinsky
    E. Hauf
    U. Keller
    K. Koch
    W. Klapper
    M. Herold
    Christian W. Scholz
    Annals of Hematology, 2020, 99 : 2821 - 2829
  • [27] Rituximab maintenance treatment in follicular lymphoma
    不详
    EJHP PRACTICE, 2011, 17 (01): : 15 - 15
  • [28] CHOP chemotherapy (ct) with rituximab and radiotherapy (RT) as a first line treatment for aggressive non-Hodqkin's lymphoma (NHL) - our experience
    Crvenkova, Simonida
    Dimitrovska, Aneta
    Mickovska, Vasiliki
    ANNALS OF ONCOLOGY, 2004, 15 : 156 - 156
  • [29] R-CHOP therapy alone for limited-stage follicular lymphoma
    Tomita, Naoto
    Suzuki, Taisei
    Ishiyama, Yasufumi
    Miyashita, Kazuho
    Takahashi, Hiroyuki
    Numata, Ayumi
    Ito, Satomi
    Motohashi, Kenji
    Tachibana, Takayoshi
    Takasaki, Hirotaka
    Kawasaki, Rika
    Hagihara, Maki
    Hashimoto, Chizuko
    Yamazaki, Etsuko
    Taguchi, Jun
    Fujimaki, Katsumichi
    Sakai, Rika
    Fujisawa, Shin
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    LEUKEMIA RESEARCH, 2015, 39 (06) : 582 - 585
  • [30] POLYMORPHIC METABOLISM OF CYCLOPHOSPHAMIDE: INFLUENCE ON CLINICAL EFFICACY OF CHOP AND R-CHOP THERAPY OF FOLLICULAR LYMPHOMA
    Haenisch, Sierk
    Boettcher, Sebastian
    Mosyagin, Igor
    Pott, Christiane
    Kneba, Michael
    Hoster, Eva
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Cascorbi, Ingolf
    DRUG METABOLISM REVIEWS, 2008, 40 : 140 - 140
12345